Results 131 to 140 of about 2,541 (204)

Neuronal conversion of single-chain tissue-type plasminogen activator into its two-chain form: implications in neurodevelopment, learning, and memory. [PDF]

Cell Death Dis
Triniac H, Lebatard S, Roussel V, Lechevallier C, Lebouvier L, Vivien D, Roussel BD.   +6 more
europepmc   +1 more source

Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure. [PDF]

Biomolecules
Bogáti R, Baráth B, Pituk D, Orbán-Kálmándi R, Szűcs P, Hegyi Z, Bereczky Z, Bagoly Z, Katona É.   +8 more
europepmc   +1 more source

STUDY OF FIBRINOLYSIN ON CLOTTED HEMOTHORAX

The Journal of Thoracic and Cardiovascular Surgery, 1964
H D, PEARSE, R M, NELSON
openaire   +2 more sources

EVALUATION OF HUMAN FIBRINOLYSIN (ACTASE)

, 1960
Anthony P. Fletcher
core   +1 more source

Contactless edema via plasmin.

Blood
Strickland S, Norris EH.
europepmc   +1 more source

Plasmin-Antiplasmin Complex as a New Predictive Marker of Postoperative Venous Thromboembolism in Patients with Gynecologic Malignancy. [PDF]

Clin Appl Thromb Hemost
Ma J, Tang Y, Zhou J, Zhao A, Shi J.
europepmc   +1 more source

Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study. [PDF]

BMC Cardiovasc Disord
Feng YF, Su MY, Xu HX, Zhang SZ, Ma YF, Chen HP.   +5 more
europepmc   +1 more source

Increased Fibrinolysin with Malignant Disease

, 1962
ROBERT C. BROWN
core   +1 more source

Mendelian randomization reveals plasminogen as a common therapeutic target for myocardial infarction and atrial fibrillation. [PDF]

J Cardiovasc Thorac Res
Charati H, Hamta A.
europepmc   +1 more source

Recombinant chymase inhibits fibrinolysis induced by endogenous plasmin in clotted human blood. [PDF]

Front Immunol
Vincent L, Lapointe C, McDonald PP, Rammos C, Rassaf T, Köllnberger M, Tinel H, Heitmeier S, D'Orléans-Juste P.   +8 more
europepmc   +1 more source